Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2583]

ESMO 2022: Cabozantinib plus nivolumab and ipilimumab shows significant PFS benefit for aRCC patients of intermediate or poor risk

ESMO 2022: Cabozantinib plus nivolumab and ipilimumab shows significant PFS benefit for aRCC patients of...

ESMO 2022: ADAURA trial results provide new hope for patients with early-stage non-small cell lung cancer

ESMO 2022: ADAURA trial results provide new hope for patients with early-stage non-small cell lung cancer

ESMO 2022: A new era of early cancer detection with blood test may change cancer screening paradigms

ESMO 2022: A new era of early cancer detection with blood test may change cancer screening paradigms

ESMO 2022: Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy

ESMO 2022: Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy

ESMO 2022: Pembrolizumab with CRT vs placebo plus CRT for locally advanced HNSCC

ESMO 2022: Pembrolizumab with CRT vs placebo plus CRT for locally advanced HNSCC

ESMO 2022: Strong potential for neoadjuvant nivolumab plus ipilimumab to become standard of care for locally advanced MMR-deficient colon cancer

ESMO 2022: Strong potential for neoadjuvant nivolumab plus ipilimumab to become standard of care for locally...

ESMO 2022: Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma

ESMO 2022: Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma

New major survey finds ‘healthy’ suntan myths persist despite warnings about skin cancer and aging

New major survey finds ‘healthy’ suntan myths persist despite warnings about skin cancer and aging

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

Study uncovers possible path for improving T cell therapies

Study uncovers possible path for improving T cell therapies

More from ecancer